The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INOVIO PHARMACEUTICALS, INC. (INO),
CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 7, 2026
(LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Is The Lawsuit About? The complaint filed alleges that, between October 10, 2023 and December 26, 2025, Defendants failed to disclose to investors that: (1) manufacturing for Inovio's CELLECTRA device was deficient; (2) accordingly, Inovio was unlikely to submit the INO-3107 BLA to the FDA by the second half of 2024; (3) Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (4) accordingly, INO-3107's overall regulatory and commercial prospects were overstated; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact: Howard G. Smith, Esq., Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Call us at: (215) 638-4847Email us at: howardsmith@howardsmithlaw.com, Visit our website at: www.howardsmithlaw.com.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us: Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
View original content:https://www.prnewswire.com/news-releases/inovio-pharmaceuticals-inc-ino-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302698541.html
SOURCE Law Offices of Howard G. Smith
https://rt.newswire.ca/rt.gif?NewsItemId=PH96383&Transmission_Id=202602261200PR_NEWS_USPR_____PH96383&DateId=20260226